Clinical Trial Update: An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ

View source ↗

Summary

Clinical trial evaluating the effectiveness and safety of fixed-dose combinations FMS/AML or FMS/AML/HCTZ for essential hypertension; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• FMS/AML (fimasartan/amlodipine)
• FMS/AML/HCTZ (fimasartan/amlodipine/hydrochlorothiazide)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Hypertension,Essential | Status: RECRUITING